Author: Ashley Aguillard Editor: Michaela Price This article will cover a well-known class of drugs for type 2 diabetes (T2D), GLP-1 receptor agonists
DPP4 inhibition leads to greater bioavailability of these proteins and therefore prolongs the half-life of insulin action
Working with a clinician means: Any changes are spotted early Risks like sudden blood sugar spikes or rapid regain are reduced You have guidance on whether to stay off, restart, or adjust your dose In short, medical support gives you a safety net so youre not left guessing
Monitoring Your Thyroid While on GLP-1 Therapy Patients starting semaglutide or tirzepatide should schedule follow-up thyroid labs 46 weeks after beginning treatment and again at 3 months if hyperthyroidism is part of your medical history
This includes adopting a balanced diet and increasing daily physical activity, both of which are integral to achieving long-term weight loss success
One employer in Nomi Health's data found GLP-1 users had 40% lower medical costs despite 2.5x higher pharmacy spend, with fewer prescriptions for comorbidities and better health markers overall
